HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,961-6,972 of 27,277
Drug study icon
CompletedNCT00351936

A Cross-Over study of Aripiprazole

Official study title

A Placebo-Controlled, Cross-Over Trial of Aripiprazole Added to Obese Olanzapine-Treated Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
North Suffolk Mental Health Association
Drug study icon
Active Not RecruitingNCT06809218

A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol

Official study title

INSPiRE-ICU 1 & 2: A Pooled Analysis of Long-Term Outcomes at 3 and 6 Months After Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients

This study is no longer accepting new participants.

In Nashville
PTSDMedication studyAges 18+
Countries
United States
Sponsor
Sedana Medical
Behavioral study icon
WithdrawnACTRN12613001167752

A Positive Psychology Intervention to Reduce Suicide prevention and Behaviour

Official study title

A randomised controlled trial evaluating a positive psychology intervention in reducing the severity and intensity of suicidal thoughts and behaviour in individuals presenting to emergency department with suicidal thoughts or behaviour

This study was withdrawn before enrollment.

In New Zealand
SuicidalityInterventional studyAges 16+
Countries
New Zealand
Sponsor
Kosta Tabakakis (PhD Candidate)
Drug study icon
TerminatedNCT00934635

Positron-Emission-Tomography Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone for schizophrenia

Official study title

The "Therapeutic Window" of the "Atypical" Antipsychotic Paliperidone Extended Release (ER)-A Positron Emission Tomography Study With [18F]Fallypride as the Radiotracer

This study ended early.

In Aachen
SchizophreniaMedication studyAges 18–50
Countries
Germany
Sponsor
Janssen-Cilag G.m.b.H
Drug study icon
CompletedACTRN12620000928910

A practice based study of a combination of nutritional interventions: probiotics, glutamine and fish oils in patients experiencing psychological distress.

Official study title

Investigating the effect of a novel nutritional intervention (probiotics, glutamine and fish-oil) on mild-moderate psychological distress in adults: a concurrent multiple baseline design

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18–65
Countries
Australia
Sponsor
Southern Cross University
Drug study icon
CompletedEUCTR 2010-022184-35

A pragmatic randomised double-blind trial of Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis: The ATLAS Trial

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
SchizophreniaHistorical research record
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.